| Literature DB >> 29502920 |
Ayman W El-Hattab1, Mohammed Almannai2, V Reid Sutton3.
Abstract
Newborn screening programs aim to achieve presymptomatic diagnosis of treatable disorders allowing for early initiation of medical care to prevent or reduce significant morbidity and mortality. Many of the conditions included in the newborn screening panels are inborn errors of metabolism; however, screening for endocrine, hematologic, immunologic, and cardiovascular diseases, and hearing loss is also included in many panels. Newborn screening tests are not diagnostic and therefore diagnostic testing is needed to confirm or exclude the suspected diagnosis. Further advancement in technology is expected to allow continuous expansion of newborn screening.Entities:
Keywords: Inborn errors of metabolism; Newborn screening; Tandem mass spectroscopy
Mesh:
Year: 2017 PMID: 29502920 DOI: 10.1016/j.pcl.2017.11.013
Source DB: PubMed Journal: Pediatr Clin North Am ISSN: 0031-3955 Impact factor: 3.278